Sarah Sammons, MD

Sarah Sammons, MD, is associate director of the Metastatic Breast Cancer Program at Dana-Farber Cancer Institute.

Articles by Sarah Sammons, MD

Sarah Sammons, MDHR Breast Cancer | June 12, 2025

Dr. Sammons on RLY-2608 plus fulvestrant in HR+/HER2– mBC with PIK3CA mutations: safety, efficacy, and trial updates.